|
Volumn 26, Issue 9, 2016, Pages 2293-2296
|
Creation of a S1P Lyase bacterial surrogate for structure-based drug design
|
Author keywords
Crystal structure; Homology modeling; S1P Lyase; Site directed mutagenesis
|
Indexed keywords
ANTIINFECTIVE AGENT;
BACTERIAL PROTEIN;
CHIMERIC PROTEIN;
ISOXAZOLE;
N [1 [4 (3 HYDROXYPROP 1 YN 1 YL)PHENYL) 2 ((4 METHOXY 2,5 DIMETHYLBENZYL)AMINO]ETHYL] 5 METHYLISOZAZOLE 3 CARBOXAMIDE;
N [2 ((4 METHOXY 2,5 DIMETHYLBENZYL)AMINO) 1 PHENYLETHYL] 5 METHYLISOXAZOLE 3 CARBOXAMIDE;
PROTEIN INHIBITOR;
REAGENT;
SPHINGOSINE 1 PHOSPHATE;
UNCLASSIFIED DRUG;
LYASE;
SPHINGOSINE 1-PHOSPHATE LYASE (ALDOLASE);
ARTICLE;
BACTERIUM;
BACTERIUM MUTANT;
CRYSTAL STRUCTURE;
CRYSTALLOGRAPHY;
DRUG DESIGN;
NONHUMAN;
PROTEIN STRUCTURE;
SITE DIRECTED MUTAGENESIS;
STRUCTURE ANALYSIS;
SYMBIOBACTERIUM THERMOPHILUM;
X RAY ANALYSIS;
CHEMISTRY;
ENZYMOLOGY;
ESCHERICHIA COLI;
METABOLISM;
X RAY CRYSTALLOGRAPHY;
ALDEHYDE-LYASES;
CRYSTALLOGRAPHY, X-RAY;
DRUG DESIGN;
ESCHERICHIA COLI;
|
EID: 84961279085
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2016.02.084 Document Type: Article |
Times cited : (11)
|
References (10)
|